Viridian Therapeutics, Inc.\DE Annual Interest Expense in USD from 2013 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Viridian Therapeutics, Inc.\DE quarterly/annual Interest Expense history and growth rate from 2013 to 2022.
  • Viridian Therapeutics, Inc.\DE Interest Expense for the quarter ending June 30, 2023 was $200K, unchanged year-over-year.
  • Viridian Therapeutics, Inc.\DE Interest Expense for the twelve months ending June 30, 2023 was $700K.
  • Viridian Therapeutics, Inc.\DE annual Interest Expense for 2022 was $500K.
  • Viridian Therapeutics, Inc.\DE annual Interest Expense for 2016 was $95K, a 32.6% decline from 2015.
  • Viridian Therapeutics, Inc.\DE annual Interest Expense for 2015 was $141K, a 86.2% decline from 2014.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $500K Jan 1, 2022 Dec 31, 2022 10-K 2023-03-09
2016 $95K -$46K -32.6% Jan 1, 2016 Dec 31, 2016 10-K 2017-03-24
2015 $141K -$882K -86.2% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-24
2014 $1.02M -$940K -47.9% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-21
2013 $1.96M Jan 1, 2013 Dec 31, 2013 10-K 2015-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.